These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 2850062)
1. Effect of captopril on the bradykinin-induced release of prostacyclin from guinea-pig lungs and bovine aortic endothelial cells. de Nucci G; Warner T; Vane JR Br J Pharmacol; 1988 Nov; 95(3):783-8. PubMed ID: 2850062 [TBL] [Abstract][Full Text] [Related]
2. Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells. White DG; Martin W Br J Pharmacol; 1989 Jul; 97(3):683-90. PubMed ID: 2547481 [TBL] [Abstract][Full Text] [Related]
3. Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells. Richards JM; Gibson IF; Martin W Br J Pharmacol; 1991 Jan; 102(1):203-9. PubMed ID: 1646057 [TBL] [Abstract][Full Text] [Related]
4. Kinins act on B1 or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells. D'Orléans-Juste P; de Nucci G; Vane JR Br J Pharmacol; 1989 Apr; 96(4):920-6. PubMed ID: 2545298 [TBL] [Abstract][Full Text] [Related]
5. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. de Nucci G; Gryglewski RJ; Warner TD; Vane JR Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2334-8. PubMed ID: 2832851 [TBL] [Abstract][Full Text] [Related]
6. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. Lückhoff A; Pohl U; Mülsch A; Busse R Br J Pharmacol; 1988 Sep; 95(1):189-96. PubMed ID: 3064851 [TBL] [Abstract][Full Text] [Related]
7. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin. Wiemer G; Schölkens BA; Becker RH Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350 [TBL] [Abstract][Full Text] [Related]
8. Different patterns of release of endothelium-derived relaxing factor and prostacyclin. Mitchell JA; de Nucci G; Warner TD; Vane JR Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103 [TBL] [Abstract][Full Text] [Related]
9. Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRF. Clesham G; Parsaee H; Joseph S; McEwan JR; MacDermot J Cardiovasc Res; 1992 May; 26(5):513-7. PubMed ID: 1446322 [TBL] [Abstract][Full Text] [Related]
10. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485 [TBL] [Abstract][Full Text] [Related]
11. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells. Mitchell JA; de Nucci G; Warner TD; Vane JR Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092 [TBL] [Abstract][Full Text] [Related]
13. Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells. Parsaee H; McEwan JR; Joseph S; MacDermot J Br J Pharmacol; 1992 Dec; 107(4):1013-9. PubMed ID: 1361398 [TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin I converting enzyme (ACE) related substances upon the vascular prostacyclin generation. Nakagawa M; Sawada S; Uno M; Takamatsu H; Nakamura Y; Nakanishi Y; Tsuji H; Toyoda T; Sasaki S; Takeda K Agents Actions Suppl; 1987; 22():55-60. PubMed ID: 2829599 [TBL] [Abstract][Full Text] [Related]
15. Regulation of prostacyclin generation by angiotensin converting enzyme related substances in cultured human vascular endothelial cells. Nakagawa M; Sawada S; Toyoda T; Takamatsu H; Tsuji H; Ijichi H Clin Exp Hypertens A; 1987; 9(2-3):405-8. PubMed ID: 3038403 [TBL] [Abstract][Full Text] [Related]
16. Prostacyclin-mediated protection by angiotensin-converting enzyme inhibitors against injury of aortic endothelium by free radicals. Liao DF; Chen X Cardioscience; 1992 Jun; 3(2):79-84. PubMed ID: 1379480 [TBL] [Abstract][Full Text] [Related]
17. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Hock FJ; Wirth K; Albus U; Linz W; Gerhards HJ; Wiemer G; Henke S; Breipohl G; König W; Knolle J Br J Pharmacol; 1991 Mar; 102(3):769-73. PubMed ID: 1364851 [TBL] [Abstract][Full Text] [Related]
18. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations. Lembeck F; Griesbacher T; Eckhardt M Br J Pharmacol; 1990 May; 100(1):49-54. PubMed ID: 2164861 [TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin I converting enzyme (ACE)-related substances on prostacyclin generation and ACE activity of human vascular endothelial cells and rat aortic rings. Nakagawa M; Sawada S; Uno M; Takamatsu H; Nakamura Y; Nakanishi Y; Tsuji H; Toyoda T; Sasaki S; Takeda K J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S113-5. PubMed ID: 2485042 [TBL] [Abstract][Full Text] [Related]
20. Endothelium-derived relaxing factor released from cultured cells: differentiation from nitric oxide. Dusting GJ; Read MA; Stewart AG Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):83-92. PubMed ID: 3271606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]